Microba Life Sciences Limited announced that Dr. Caroline Popper intends to resign from Microba's Board of Directors, effective 14 June 2023, for personal reasons. Dr. Popper joined the Microba Board of Directors as a Non-Executive Director in January 2020 and has brought valuable insights and experience to the Microba Board. Dr. Popper has been part of the transition of Microba Life Sciences to an ASX listed company in April 2022.

The Company is in the process of identifying a suitably qualified and experienced United States based candidate to join Microba's Board of Directors, to assist the Company's next phase of advancement and growth.